Table 2.

Excluded outcomes

Outcome	Mean (SD)
Encourage shared decision making	4.42 (0.58)
Select appropriate end-points to assess efficacy	4.38 (0.75)
Select an appropriate drug for the condition based on evaluation of the evidence for its safety, efficacy and cost	4.29 (0.78)
Minimize waste in prescribing	4.27 (0.60)
Identify when there is a pharmacological prophylaxis should be given with the main drug being prescribed*	4.25 (0.86)
Administer medicines parenterally (s.c., i.m., i.v.)	4.19 (0.75)
Complete a yellow ‘card’ for a suspected ADR	4.19 (0.63)
Encourage patient compliance*	4.10 (0.79)
Participate in audit of prescribing*	4.05 (0.80)
Use capital letters when writing a prescription	4.00 (0.89)
Prepare parenteral medications	3.88 (0.91)
Assess cost–benefit for specific therapies in specific patients*	3.57 (0.50)

^*New outcomes suggested by panellists during the Delphi process. Underlined items are those that were previously in the 2003 BPS curriculum, or in the British National Formulary. ADR, adverse drug reaction.